von Au, A., Milloth, E., Diel, I., Stefanovic, S., Hennigs, A., Wallwiener, M., . . . Domschke, C. (2016). Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: A randomized, open-label, non-inferiority Phase III trial. Onco Targets Ther.
Chicago Style aipamenavon Au, Alexandra, et al. "Intravenous Pamidronate Versus Oral and Intravenous Clodronate in Bone Metastatic Breast Cancer: A Randomized, Open-label, Non-inferiority Phase III Trial." Onco Targets Ther 2016.
MLA aipamenavon Au, Alexandra, et al. "Intravenous Pamidronate Versus Oral and Intravenous Clodronate in Bone Metastatic Breast Cancer: A Randomized, Open-label, Non-inferiority Phase III Trial." Onco Targets Ther 2016.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.